<DOC>
	<DOC>NCT01557257</DOC>
	<brief_summary>To characterize the single- and multiple-dose pharmacokinetics of oxycodone following the administration of ALO-02 40 Mg Twice Daily, ALO-02 80 Mg Once Daily or Oxycontin 40 Mg Twice Daily in Healthy Volunteers</brief_summary>
	<brief_title>Pharmacokinetics Study of ALO-02 and OxyContin</brief_title>
	<detailed_description />
	<mesh_term>Oxycodone</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<criteria>Healthy male and/or female subjects between the ages of 18 and 55 years, inclusive. Evidence or history of clinically significant diseases.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>single- and multiple-dose pharmacokinetics</keyword>
	<keyword>ALO-02</keyword>
	<keyword>OxyContin</keyword>
</DOC>